Gemcira RTU 1 gm Injection 26.3 ml

Gemcira RTU 1 gm Injection 26.3 ml belongs to the group of anti-cancer drugs called cytotoxics used alone or in combination with other anti-cancer drugs to treat various types of cancers like breast cancer, pancreatic cancer, non-small cell lung cancer, bladder cancer, and ovarian cancer. Cancer is the uninhibited and uncontrolled growth of cells in the body.

Gemcira RTU 1 gm Injection 26.3 ml contains Gemcitabine which works by interfering with the synthesis of DNA, thereby causing cell death and arresting the uncontrolled production of new cells. Thus, Gemcira RTU 1 gm Injection 26.3 ml is very effective in controlling cancer cells from multiplying and is used in the treatment of various types of cancers. 

A healthcare professional will administer Gemcira RTU 1 gm Injection 26.3 ml. Do not self-administer. Gemcira RTU 1 gm Injection 26.3 ml may cause certain common side effects such as nausea, hair loss, skin rash, vomiting, and oedema. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if these side effects persist. 

It is advisable to inform the doctor if you are allergic to any of the components. Consult your doctor if you are pregnant, planning to get pregnant, or breastfeeding. Talk to your doctor if you are planning to father a child before taking Gemcira RTU 1 gm Injection 26.3 ml; your doctor may advise you regarding sperm storage. Avoid taking alcohol with Gemcira RTU 1 gm Injection 26.3 ml.

Gemcira RTU 1 gm Injection 26.3 ml is used in the treatment of Breast Cancer, Pancreatic Cancer, Non-small-cell Lung Cancer, Bladder Cancer, and Ovarian Cancer. The detailed use of Gemcira RTU 1 gm Injection 26.3 ml is as follows:

• Treatment of cancer: Gemcira RTU 1 gm Injection 26.3 ml is used to treat several types of solid tumors like pancreatic cancer, non-small cell lung cancer, breast cancer, ovarian cancer, urinary bladder cancer.

• Your doctor will decide the dosage and timing of Gemcira RTU 1 gm Injection 26.3 ml based on the type of cancer and your body's response to the treatment.
• Gemcira RTU 1 gm Injection 26.3 ml will be administered by the doctor or nurse in a medical setting.
• Do not self-administer it.

Gemcira RTU 1 gm Injection 26.3 ml is an anti-cancer drug used in the treatment of various types of cancers. Gemcira RTU 1 gm Injection 26.3 ml is used either independently or in conjunction with other chemotherapy medications to treat breast cancer, pancreatic cancer, non-small cell lung cancer, bladder cancer, and ovarian cancer. Gemcira RTU 1 gm Injection 26.3 ml works by interfering with DNA synthesis. It blocks the production of new DNA, by locking itself into the DNA strands and inhibiting any further proliferation or growth of the cell. Hence, Gemcira RTU 1 gm Injection 26.3 ml has widespread application in the field of oncology (cancer-related medicine) and chemotherapy.

Gemcira RTU 1 gm Injection 26.3 ml should not be used in case of any known allergy to any of the components. Gemcira RTU 1 gm Injection 26.3 ml should be used with caution in case of high risk or previous history of heart disease, vascular disease, liver problems, kidney disease or alcoholism. Keep your doctor informed if you suffer from any shortness of breath, kidney problems, hypertension diabetes or epilepsy. Avoid Gemcira RTU 1 gm Injection 26.3 ml during pregnancy and breastfeeding. Offer a detailed medical history, vaccination history, and inform the doctor especially if you are on any radiotherapy.